# Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

> **NCT00002761** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interferon gamma
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** cytarabine
- **DRUG:** idarubicin
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00002761
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1996-02
- **Primary completion:** 2007-02
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2012-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002761, "Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00002761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*